Funded Biotechnology Startups in France
Within the 50 most recent France biotechnology rounds shown, the largest disclosed amount is Inventiva Pharma’s $120M on 2026-06-02; it dwarfs the rest of…
Within the 50 most recent France biotechnology rounds shown, the largest disclosed amount is Inventiva Pharma’s $120M on 2026-06-02; it dwarfs the rest of the disclosed rounds, which mostly sit well below that level (e.g., Nanobiotix at $116M on 2026-05-21 and TISSIUM at $34M on 2026-06-24 are far smaller than $120M). At the low end, Kahimmune Therapeutics’ $120K on 2026-04-28 is the smallest disclosed amount, creating a wide spread from $120K to $120M across the same list.
The timing clusters heavily: many disclosed rounds fall in a late-spring 2025 to late-spring 2026 window, with several notable entries in May 2026 (Nanobiotix $116M on 2026-05-21; Sensorion $72M on 2026-01-28 is earlier but still within the same recent-year concentration). Geography also concentrates: Paris/Ile-de-France appears repeatedly (e.g., TISSIUM 2026-06-24; Abivax 2026-05-05; DBV Technologies 2025-10-06), while funding sizes also show an outlier profile around very large checks (Inventiva Pharma $120M, Nanobiotix $116M, Sensorion $72M). Stage classification is also skewed toward “Series Unknown” (24 of 50 rows), with additional “undisclosed” amounts appearing in 3 rows (One Biosciences 2026-06-18; TheraPPI Bioscience 2026-06-01; Hi-Tech Detection Systems 2026-05-20).
Most recent rounds
50 of 155105 more funded startups
This page shows the 50 most recent rounds (back to May 2025). The full 155-company history for this listing is available on a paid plan.
Unlock all 155 companies in this listing — full funding history, investors, and founders.
Related listings
Frequently asked
Which disclosed round is the size outlier, and what’s the next-largest disclosed amount in this set?
Inventiva Pharma’s $120M on 2026-06-02 is the largest disclosed amount, followed by Nanobiotix’s $116M on 2026-05-21; both sit far above other disclosed rounds such as TISSIUM’s $34M on 2026-06-24 and Abionyx Pharma’s $12M on 2026-05-27.
How concentrated are the funding dates in the most recent period shown?
The list’s most recent entry is TISSIUM on 2026-06-24, and multiple top-end rounds cluster in May–June 2026, including Nanobiotix ($116M, 2026-05-21), Inventiva Pharma ($120M, 2026-06-02), and TISSIUM ($34M, 2026-06-24).
Are any cities over-represented among the headquarters locations in this France biotech list?
Paris/Ile-de-France appears frequently across different deal sizes and dates, including TISSIUM (2026-06-24, $34M), Abivax (2026-05-05, $45M), DBV Technologies (2025-10-06, $30M), and ENTEROME (2025-06-12, $19M).
What’s the stage mix looking like, and how much classification is missing or unavailable?
“Series Unknown” is the dominant label with 24 of 50 rows, including Advicenne (2026-06-22, $2M) and GenSight Biologics (2026-03-10, $2M). Amounts are also missing in 3 rows marked “undisclosed,” including One Biosciences on 2026-06-18 and TheraPPI Bioscience on 2026-06-01.
Which entry is the smallest disclosed amount, and how extreme is the gap versus the largest disclosed round?
Kahimmune Therapeutics’ $120K on 2026-04-28 is the smallest disclosed amount, creating a large spread relative to Inventiva Pharma’s $120M on 2026-06-02. That range spans from the sub-$1M bracket (e.g., Aelis Farma $530K on 2026-04-07) up to the triple-digit millions.
Do the largest checks cluster in the same geography or are they spread across France?
The top two disclosed rounds are Paris-adjacent/large hubs and not evenly distributed: Nanobiotix is in Paris (2026-05-21, $116M) while Inventiva Pharma is in Daix (2026-06-02, $120M). Other large disclosed rounds also appear outside Paris, such as Sensorion in Clapiers (2026-01-28, $72M).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.